Welcome to our dedicated page for HALLIBURTON CO SEC filings (Ticker: HAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HALLIBURTON CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HALLIBURTON CO's regulatory disclosures and financial reporting.
Halliburton (HAL) received a Form 144 notice for a proposed sale of 160,000 common shares. The filing lists an aggregate market value of $4,443,200 for the planned sale, with trades expected around 11/12/2025 on the NYSE. Fidelity Brokerage Services LLC is named as the broker.
As context, 841,626,610 shares were outstanding at the time stated. The seller’s share history includes acquisitions via restricted stock vesting, dividend reinvestment, and ESPP purchases across 2018–2024.
Halliburton Company reported softer Q3 2025 results as industry activity slowed and one-time charges weighed on earnings. Revenue was $5.6 billion, down 2% year over year, with operating income of $356 million versus $871 million a year ago. Net income was $18 million, or $0.02 per share, compared with $571 million, or $0.65 per share, in Q3 2024.
Results reflected $392 million in impairments and other charges, including severance, asset write-offs, and an impairment tied to assets held for sale. The effective tax rate rose to 90.9% due to a $125 million valuation allowance on deferred tax assets, combined with the quarter’s charges. Segment revenue declined 2% in Completion & Production and was relatively flat in Drilling & Evaluation; Europe/Africa/CIS grew 15% while Middle East/Asia fell 8%.
Year-to-date operating cash flow was $1.8 billion, funding $917 million of capex, $757 million of share repurchases (32.9 million shares), and $436 million in dividends. Cash and equivalents were $2.0 billion, and a new $3.5 billion five‑year revolving credit facility was fully available at quarter-end. As of October 17, 2025, 841,626,610 common shares were outstanding.
Halliburton Company furnished an 8‑K announcing it issued a press release with financial results for the quarter ended September 30, 2025, and access details for an investor conference call. The call had been previously announced on September 18, 2025.
The information under Items 2.02 and 7.01, and the press release attached as Exhibit 99.1, is deemed “furnished,” not “filed,” under SEC rules. The press release includes certain non‑GAAP financial measures with reconciliations to the most directly comparable GAAP metrics. The release will also be available on the company’s website.
Halliburton Company filed an 8‑K under Item 8.01 disclosing details of its previously reported minority interest in Voltagrid. The company states its fully diluted ownership in Voltagrid is approximately 20%. This updates prior disclosure by quantifying the stake on a fully diluted basis.
Maurice S. Smith, a Halliburton (HAL) director, reported acquisitions and existing holdings under director compensation plans. The filing shows 1,372.04 stock equivalent units acquired on 09/29/2025 under the Halliburton Directors' Deferred Compensation Plan, with a portion attributable to quarterly dividends and fees based on closing prices of $24.44 on September 24, 2025 and $25.00 on September 29, 2025. The report also lists restricted stock units vesting after one year from grant dates in 12/2024, 12/2023 and 03/2023, and totals of 11,728.754 shares and additional stock equivalent balances of 6,226.77, 5,040.19 and 4,028.23 respectively as reported through September 30, 2025. The units convert one-for-one to common stock and may be settled upon cessation as a director.
Capital Research Global Investors reported beneficial ownership of 87,801,964 shares of Halliburton Co. That stake represents 10.3% of the 852,602,102 shares the filer believes are outstanding. The filing shows CRGI has sole voting power over 87,801,953 shares and sole dispositive power over 87,801,964 shares. The firm states these shares are held in the ordinary course of business and were not acquired to change or influence control of Halliburton. The filing was made on an amendment to Schedule 13G and signed by an authorized officer of Capital Research.
Halliburton Company entered into a new U.S. $3,500,000,000 five-year revolving credit agreement on August 18, 2025. The facility is with a syndicate of banks and Citibank, N.A. as agent and is intended for general working capital purposes, with a stated termination date of August 16, 2030.
This 2025 credit agreement replaces Halliburton’s prior U.S. $3,500,000,000 five-year revolving credit agreement dated April 27, 2022, which was terminated the same day. The company filed the full 2025 credit agreement as an exhibit for reference.
Capital Research Global Investors (CRGI) reports beneficial ownership of 50,061,312 shares of Halliburton common stock, representing 5.8% of the shares believed to be outstanding. CRGI states it has sole voting power over 50,061,245 shares and sole dispositive power over 50,061,312 shares. The filing identifies CRGI as an investment management division of Capital Research and Management Company and affiliated entities that provide investment services under the name Capital Research Global Investors. The statement affirms these shares were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer.
Stephanie Holzhauser Spoelker, Halliburton's SVP & Chief Accounting Officer, submitted an initial Form 3 disclosing direct ownership of 67,685 shares of common stock and two stock option grants: 9,688 options exercisable through 01/02/2028 at $49.61, and 7,994 options exercisable through 01/03/2027 at $55.68. The filing records these holdings following a 07/16/2025 transaction.
Halliburton (HAL) Q2 2025 10-Q highlights
- Top-line: Revenue fell 6% YoY to $5.51 bn; North America –9%, Latin America –11%. Europe/Africa/CIS +8% was the lone growth region.
- Profitability: Operating income declined 30% to $727 m; margin compressed to 13.2% (17.7%). Net income attributable to shareholders dropped 33% to $472 m; EPS $0.55 vs $0.80.
- YTD impact: $356 m of severance, asset and facility impairments drove a 47% EPS contraction to $0.78 and lifted the effective tax rate to 25.5%.
- Cash & leverage: Operating cash flow down 19% to $1.27 bn; FCF after $656 m capex was $0.62 bn. Cash balance slipped to $2.04 bn (-22%) while total debt held steady at $7.16 bn; no near-term covenant pressure and $3.5 bn credit revolver available.
- Capital returns: 12 m shares repurchased for $252 m; 21.5 m YTD for $507 m. Quarterly dividend maintained at $0.17; board still targeting ≥50% of annual FCF to shareholders.
- Segment trends: Completion & Production revenue –7%, operating income –29%; Drilling & Evaluation revenue –4%, operating income –23%—reflecting weaker pressure pumping, Saudi/Mexico activity cuts and price pressure.
- Outlook: Management now expects 2025 revenue to decline in both North America and internationally, citing tariff-related demand uncertainty and faster-than-expected OPEC+ supply. Capex guidance unchanged at ~6% of revenue.
- Risks: $909 m CDS exposure to Mexican customer, potential $640 m tax cash outflow from IRS dispute, and SAP S4 migration costs may extend beyond prior $270 m estimate.